Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Chen, F; Zhu, Y; Tang, X; Sun, Y; Jia, W; Sun, Y; Han, X.
Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction.
Endocrinology. 2011; 152(5): 1779-1788.
Doi: 10.1210/en.2010-1048
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Sun Yidan
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Transcription factors forkhead box (Fox)O1 and pancreatic and duodenal homeobox-1 (PDX-1) are involved in dexamethasone (DEX)-induced dysfunction in pancreatic β-cells. However, the molecular mechanism underlying the regulation of FoxO1 and PDX-1 expression in β-cells treated with DEX is not fully understood. In this study, we found that DEX markedly increased FoxO1 mRNA and protein expression, whereas it decreased PDX-1 mRNA and protein expression in a dose- and time-dependent manner. Further study showed that FoxA2 was involved in regulation of FoxO1 and PDX-1 expression in DEX-induced pancreatic β-cells dysfunction. Interestingly, we demonstrated for the first time that FoxA2 could bind to the FoxO1 gene promoter and positively regulate FoxO1 expression. Moreover, we found that DEX increased the activity of FoxA2 binding to the FoxO1 promoter but decreased the activity of FoxA2 binding to the PDX-1 promoter of RINm5F cells. Knockdown of FoxA2 by RNA interference inhibited FoxO1 expression and restored PDX-1 expression in pancreatic β-cells treated with DEX. However, DEX had no effect on the expression of FoxA2. Together, the results of the present study demonstrated that FoxA2 could dynamically regulate FoxO1 and PDX-1 expression in pancreatic β-cells treated with DEX, which provides new important information on the transcriptional regulation of FoxO1 and PDX-1 in DEX-induced pancreatic β-cells. Inhibition of FoxA2 can effectively protect β-cells against DEX-induced dysfunction.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Blotting, Western -
- Cell Line, Tumor -
- Chromatin Immunoprecipitation -
- Dexamethasone - pharmacology
- Dose-Response Relationship, Drug -
- Forkhead Transcription Factors - genetics
- Gene Expression Regulation - drug effects
- Glucocorticoids - pharmacology
- Hepatocyte Nuclear Factor 3-beta - genetics
- Homeodomain Proteins - genetics
- Insulin-Secreting Cells - drug effects
- Male -
- Nerve Tissue Proteins - genetics
- Promoter Regions, Genetic - genetics
- Protein Binding - drug effects
- RNA Interference -
- Rats -
- Rats, Sprague-Dawley -
- Reverse Transcriptase Polymerase Chain Reaction -
- Time Factors -
- Trans-Activators - genetics